proteinosis - Robuta Search

https://pubmed.ncbi.nlm.nih.gov/5841935/ [Pulmonary alveolar proteinosis (a probable case)] [Pulmonary alveolar proteinosis (a probable case)] pulmonary alveolar probable case https://scholars.duke.edu/publication/733057 Scholars@Duke publication: Alveolar proteinosis: a disease of mice and men. scholars duke publication alveolar https://pubmed.ncbi.nlm.nih.gov/40603093/ Secondary Pulmonary Alveolar Proteinosis Complicated by Hemophagocytic Syndrome in a Patient with... Treatment of secondary pulmonary alveolar proteinosis (SPAP) focuses on managing the underlying disease, typically myelodysplastic syndrome. However,... https://medlineplus.gov/ency/article/000114.htm Pulmonary alveolar proteinosis: MedlinePlus Medical Encyclopedia Pulmonary alveolar proteinosis (PAP) is a rare disease in which a type of protein builds up in the air sacs (alveoli) of the lungs, making breathing difficult.... pulmonary alveolar medlineplus medical encyclopedia https://rarediseases.info.nih.gov/diseases/3268/lipid-proteinosis Lipid proteinosis | About the Disease | GARD Find symptoms and other information about Lipid proteinosis. about the disease lipid gard https://www.impala2.com/ About Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - IMPALA-2 Dec 14, 2021 - (aPAP) is a rare lung disease that occurs most frequently in people between the ages of 30 and 40. Click to read more about our IMPALA-2 aPAP clinical trial. autoimmune pulmonary alveolar apap impala https://pubmed.ncbi.nlm.nih.gov/34408422/ Update on Diagnosis and Treatment of Adult Pulmonary Alveolar Proteinosis Pulmonary alveolar proteinosis (PAP) is a rare pulmonary surfactant homeostasis disorder resulting in buildup of lipo-proteinaceous material within the... diagnosis and treatment update adult pulmonary alveolar https://experts.mcmaster.ca/scholarly-works/1512381 Pulmonary Alveolar Proteinosis in Setting of... Learn about the scholarly work entitled Pulmonary Alveolar Proteinosis in Setting of... pulmonary alveolar setting